Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on BARCLAYS PLC. We currently have 3 research reports from 1 professional analysts.
|02Dec16 01:30||RNS||Holding(s) in Company|
|01Dec16 11:30||RNS||Total Voting Rights|
|30Nov16 07:02||RNS||Barclays passes 2016 BoE stress test|
|10Nov16 03:00||RNS||Director/PDMR Shareholding|
|01Nov16 12:00||RNS||Total Voting Rights|
|28Oct16 04:00||RNS||Publication of Suppl.Prospcts|
|27Oct16 07:00||RNS||3rd Quarter Results|
Frequency of research reports
Research reports on
One-off coverage increase on UK and US credit card portfolios
27 Oct 16
The reported quarterly performance was impacted by a one-off provision charge on UK and US credit card portfolios. The additional PPI-related provision was offset by the gain on the sale of Barclays Analytics and Index Solutions. The core division has continued to enjoy good revenue momentum and efficiency gains while the run-off of the non-core division has remained on track with the objective to close it in 2017.
Chosen final destination; ticket price uncertain
30 Mar 16
The group’s refocusing on the UK and the US has been strengthened further with the enlargement of the non-core assets to be divested and the decision to deconsolidate Africa. The investment bank still has room to improve its profitability further through ongoing efficiency gains and better capital usage. The visibility on the residual value adjustments required to run-down non-core assets has increased. The uncertainty surrounding future litigation charges now mostly concerns the settlement of the US RMBS inquiry. The temporary dividend cut decision seems to be partly motivated by pending extra management actions to reduce both operating and funding costs to bolster future profitability potential.
Don’t mess with IBK
09 Jul 15
Anthony Jenkins was fired on Wednesday after three years as CEO. The market reaction speaks for itself: the share price was up by 4% intraday before closing up 2%. According to the FT, Jenkins’ removal could result from a conflict with Tom King, the head of the IBK division. John McFarlane, the bank’s Chairman, will be the interim CEO until a new CEO is found, maybe the CFO.
Positive returns from all asset classes in Q316
28 Nov 16
Tetragon Financial Group (TFG) reported fair value earnings of US$49.7m for the third quarter of 2016, with positive contributions made by all asset classes. NAV total return was 1.3% for the quarter and 7.8% for the nine months to 30 September 2016. Having completed a US$100m tender offer in June 2016, TFG commenced a US$50m tender offer on 9 November 2016, which should be meaningfully accretive to NAV per share given the current wide share price discount to NAV. Consistent with previous years, the third interim dividend was held in line with the second interim, confirming TFG’s 5.9% yield.
N+1 Singer - Morning Song 30-11-2016
30 Nov 16
Sanderson has delivered full year results in line with expectations and the 19 October trading update after a strong finish to the year compensated for a slower start. A healthy level of pre-contracted recurring revenue (50%), incremental sales to existing customers and new customer wins at higher average order values helped deliver solid revenue growth in both the Digital Retail (+9%) and Enterprise (+12%) divisions. A decent order book and good sales momentum suggest that the company is on track to deliver on unchanged profit expectations for the current year. We continue to view the valuation (FY17 EV/EBITDA 8.6x) as undemanding given an attractive combination of accelerating growth potential, strong cash generation and growing dividends.
Small Cap Breakfast
28 Nov 16
Warpaint London—Schedule one update. Raising £2.5m at 97p. Expected mkt cap £62.6m vs revenues of £22.3m Walls & Futures REIT — Has raised £1m at £1 to acquire, refurbish or develop residential properties in the UK . Due to arrive on ISDX on 29 November Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December. Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.
N+1 Singer - Grainger - Final results in line, further progress on PRS investment pipeline
01 Dec 16
Grainger has reported FY16 final results this morning with key NNNAV and recurring PBT metrics in line with our forecasts. Sales performance and rental income growth was strong in H2, as previewed in the positive FY trading update driving our 19% PBT upgrade in early October (11/10). The PRS investment pipeline continues to grow now standing at £389m secured and £347m in legals as Grainger pursues an £850m investment target by 2020. A 3.05p final dividend is in line with the revised policy to distribute 50% net rental income. The shares continue to trade on a significant, and unwarranted, 20%+ discount to NNNAV. We reiterate our BUY recommendation.
Interims reveal value creation
28 Nov 16
In June Draper Esprit was listed on the LSE. Today its maiden interim results reveal substantial progress since IPO. In addition to strengthening the executive team with the appointment of Ben Wilkinson as CFO, Draper Esprit has created shareholder value through new investment and realisations.